2022. Evaluation of the safety and effectiveness of the combination of gemcitabine monochemotherapy and high-intensity focused ultrasound therapy in the treatment of patients with adenogenic pancreatic cancer. Voprosy onkologii. 68, 6 (Dec. 2022), 780–785. DOI:https://doi.org/10.37469/0507-3758-2022-68-6-780-785.